MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
In my May 2020 CW column, I introduced a new test method for measuring the fracture toughness within the facesheet-to-core interface region of sandwich composites. This proposed test method, referred ...
A team of researchers from Drexel University has developed an innovative approach to rigorously test and improve the robustness of autonomous driving systems. Their study, presented this summer at ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
In this chapter, we focus on two topics: the lack of enforcement of existing U.S. Department of Defense (DOD) guidelines and procedures and the role of the program manager in the acquisition process.
This appendix presents a brief overview of the defense acquisition process. 1 The diagram below from the U.S. Department of Defense (2008:12 enclosure 2) depicts the development of defense systems as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results